Approval · Notice of Compliance 6289 · 2005
TARKA: Notice of Compliance 6289
Issued February 18, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6289
- Date
- February 18, 2005
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of pharmacokinetic data
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TARKA | Not yet assigned | — |
Medicinal ingredients
- TRANDOLAPRIL 1 MG per TAB
- VERAPAMIL HCL 180 MG per TAB
- TRANDOLAPRIL 2 MG per TAB
- VERAPAMIL HCL 240 MG per TAB
- TRANDOLAPRIL 4 MG per TAB